APIs intermediates
We are committed to the research and development, optimization and impurity characterization of organic intermediates and pharmaceutical raw materials with high technical barriers, high difficulty and high added value. At present, nearly 10 new drug technology research and development work has been completed for a number of pharmaceutical R&D companies, and nearly 30 chemical new product process development work has been completed for chemical companies.
We are a professional CDO and CDMO service provider, specializing in custom chemical services for the synthesis and production of organic compounds, including custom development of pharmaceutical intermediates, APIs and high-end chemical reagents ( CRO-FTE) and production.
We always take scientific research as our first priority, take customers as the center, carry out testing and analysis under strict procedures, provide customers with solutions for product testing and quality control, and provide professional scientific testing, R&D and analysis services to our customers. Effectively help customers develop new project technologies.
2019 10-28
Source: Xiaoshan Net - Xiaoshan Daily Following the open...
2019 10-25
The surge of 99 times! The crazy moment of the raw material phenol market has still le...
2019 10-22
On October 22nd, "I think it is a necessity to pursue the valuation of biomedical...
2019 03-11
China Medical News reporter Guo Ting During the two sessions of the National People...
2018 06-27
On June 20th, Hangzhou Municipality Implementation Opinions on Promoting the Innovativ...
